We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$62.7M +$9.67M +88,462 +22%
FP
2
Flagship Pioneering
Massachusetts
$41.6M
RG
3
Redmile Group
California
$21.4M +$11.1M +101,501 +159%
AIM
4
ARK Investment Management
Florida
$19.5M +$7.33M +67,013 +80%
DM
5
Deerfield Management
New York
$16.5M
Wellington Management Group
6
Wellington Management Group
Massachusetts
$13.4M +$373K +3,408 +3%
BlackRock
7
BlackRock
New York
$12.1M +$3.88M +35,459 +62%
Vanguard Group
8
Vanguard Group
Pennsylvania
$11.9M +$3.68M +33,676 +58%
BBA
9
Baker Bros. Advisors
New York
$7.46M
JP Morgan Chase
10
JP Morgan Chase
New York
$4.86M +$500K +4,571 +14%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$4.25M +$189K +1,732 +6%
CS
12
Candriam SCA
Luxembourg
$2.65M -$65.6K -600 -3%
State Street
13
State Street
Massachusetts
$2.62M +$121K +1,110 +6%
Northern Trust
14
Northern Trust
Illinois
$2.35M +$513K +4,693 +35%
Millennium Management
15
Millennium Management
New York
$2.13M +$1.79M +16,377 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.12M +$741K +6,781 +71%
EAM
17
Eventide Asset Management
Massachusetts
$1.95M
GCP
18
GSA Capital Partners
United Kingdom
$1.41M +$1.19M +10,890 New
BCM
19
Bridgeway Capital Management
Texas
$1.29M +$1.09M +9,970 New
Charles Schwab
20
Charles Schwab
California
$997K +$364K +3,331 +77%
OM
21
Opaleye Management
Massachusetts
$961K
PP
22
PDT Partners
New York
$849K +$39.3K +359 +6%
Connor, Clark & Lunn Investment Management (CC&L)
23
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$744K +$467K +4,270 +292%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$670K +$179K +1,637 +46%
TCIM
25
TIAA CREF Investment Management
New York
$508K +$95K +869 +29%